Current and future treatment options for perioral dermatitis

Perioral dermatitis (POD) is a persistent erythematous eruption composed of small papules and papulo–pustules localized around the mouth. POD affects children and adults. Several agents have been implicated in its pathogenesis, including cosmetics and glucocorticoids. If untreated, the classical form of POD has a tendency to persist, especially if the patient habitually uses moisturizing and/or night cream. For successful management of POD, the first step should be the discontinuation of all topical corticosteroids being used by the patient, after which the eruption usually resolves. In resistant cases, POD requires pharmacological treatment.

[1]  G. Forck,et al.  Quecksilbersensibilisierung bei Amalgamfüllungen: Beurteilung aus dermatologischer Sicht , 2008 .

[2]  S. Nedorost.  Medical Pearl: the evaluation of perioral dermatitis: Use of an extended patch test series. , 2007, Journal of the American Academy of Dermatology.

[3]  L. Eichenfield,et al.  Periorificial dermatitis in children and adolescents. , 2006, Journal of the American Academy of Dermatology.

[4]  R. Thurmayr,et al.  Critical Appraisal of Reports on the Treatment of Perioral Dermatitis , 2005, Dermatology.

[5]  T. Jansen.  Azelaic acid as a new treatment for perioral dermatitis: results from an open study , 2004, British Journal of Dermatology.

[6]  B. Amichai,et al.  Macrolactam Immunomodulators (Tacrolimus and Pimecrolimus): New Horizons in the Topical Treatment of Inflammatory Skin Diseases , 2004, The Journal of dermatology.

[7]  O. Gürbüz,et al.  Therapeutic potential of azithromycin in rosacea , 2004, International journal of dermatology.

[8]  H. Takiwaki,et al.  Differences between intrafollicular microorganism profiles in perioral and seborrhoeic dermatitis , 2003, Clinical and experimental dermatology.

[9]  Z. H. Hafeez.  Perioral dermatitis: an update , 2003, International journal of dermatology.

[10]  M. Parnham,et al.  Azithromycin modulates neutrophil function and circulating inflammatory mediators in healthy human subjects. , 2002, European journal of pharmacology.

[11]  T. Jansen.  Perioral dermatitis successfully treated with topical adapalene , 2002, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  B. Elewski.  A novel treatment for acne vulgaris and rosacea , 2000, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  C. Quirk,et al.  Topical applications and perioral dermatitis , 2000, The Australasian journal of dermatology.

[14]  J. Salvemini,et al.  Perioral dermatitis in children. , 1999, Seminars in cutaneous medicine and surgery.

[15]  G. Rossoni,et al.  Comparative anti-inflammatory effects of roxithromycin, azithromycin and clarithromycin. , 1998, The Journal of antimicrobial chemotherapy.

[16]  A. Genga,et al.  Demonstration of fusobacteria in eruptions of perioral dermatitis using the tape stripping toluidine blue (TSTB) method , 1994 .

[17]  S. Miller,et al.  Topical metronidazole gel (0.75%) for the treatment of perioral dermatitis in children. , 1994, Journal of the American Academy of Dermatology.

[18]  J. Thormann,et al.  Topical metronidazole in the treatment of perioral dermatitis. , 1991, Journal of the American Academy of Dermatology.

[19]  K. W. Smith.  Perioral dermatitis with histopathologic features of granulomatous rosacea: successful treatment with isotretinoin. , 1990, Cutis.

[20]  C. Ellis,et al.  The treatment of perioral dermatitis, acne rosacea, and seborrheic dermatitis. , 1982, The Medical clinics of North America.

[21]  J. Guin.  Complications of topical hydrocortisone. , 1981, Journal of the American Academy of Dermatology.

[22]  V. Kirton,et al.  Perioral dermatitis: a 12‐year review , 1979, The British journal of dermatology.

[23]  A. Buck,et al.  [Etiology of perioral dermatitis]. , 1977, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[24]  L. Montes,et al.  Perioral dermatitis and Candida albicans. , 1972, Archives of dermatology.

[25]  G. Ehlers.  [Rosacea-like dermatitis of the face. "Perioral dermatitis"]. , 1969, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[26]  G. Frumess,et al.  Light-sensitive seborrheid. , 1957, A.M.A. archives of dermatology.

[27]  W. Lempriere.  TREATMENT OF WARTS * , 1951, Australian journal of dermatology.

[28]  M. Barbareschi,et al.  Pulse-therapy with azithromycin in acne rosacea and perioral dermatitis: an open study , 2005 .

[29]  M. Dolenc-Voljč,et al.  Density of Demodex folliculorum in perioral dermatitis. , 2005, Acta dermato-venereologica.

[30]  J. Ring,et al.  Perioral dermatitis in children--clinical presentation, pathogenesis-related factors and response to topical metronidazole. , 1997, Dermatology.

[31]  R. Thurmayr,et al.  A topical erythromycin preparation and oral tetracycline for the treatment of perioral dermatitis: a placebo-controlled trial , 1993 .

[32]  Ferlito Ta.  Tartar-control toothpaste and perioral dermatitis. , 1992 .